Loading...
Sequana Medical NV
SEQUA.BR•EURONEXT
Healthcare
Medical - Devices
€1.53
€0.12(8.51%)
Sequana Medical NV (SEQUA.BR) Financial Performance & Statements
Review Sequana Medical NV’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-85.12%
↓ 85.12%
Operating Income Growth
36.57%
↑ 36.57%
Net Income Growth
-37.13%
↓ 37.13%
Operating Cash Flow Growth
29.74%
↑ 29.74%
Operating Margin
-9495.79%
↓ 9495.79%
Gross Margin
76.14%
↑ 76.14%
Net Profit Margin
-19519.95%
↓ 19519.95%
ROE
204.74%
↑ 204.74%
ROIC
59.26%
↑ 59.26%
Sequana Medical NV (SEQUA.BR) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Sequana Medical NV stock.
| Metric | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $500.00 | $52750.00 | $52750.00 | $164000.00 |
| Cost of Revenue | $500.00 | $13044.00 | $13044.00 | $37826.00 |
| Gross Profit | $0.00 | $39706.00 | $39706.00 | $126174.00 |
| Gross Profit Ratio | $0.00 | $0.75 | $0.75 | $0.77 |
| R&D Expenses | $0.00 | $491194.00 | $491194.00 | $972910.00 |
| SG&A Expenses | $8.50M | $4.42M | $4.42M | $6.09M |
| Operating Expenses | $8.50M | $4.91M | $4.91M | $7.06M |
| Total Costs & Expenses | -$8.97M | $4.92M | $4.92M | $7.10M |
| Interest Income | -$2.96M | $0.00 | $0.00 | $0.00 |
| Interest Expense | $21.85M | $0.00 | $0.00 | $598100.00 |
| Depreciation & Amortization | $474009.00 | $140991.00 | $70496.00 | $105444.00 |
| EBITDA | -$11.11M | -$4.73M | -$4.73M | -$6.93M |
| EBITDA Ratio | -$22225.55 | -$89.61 | -$89.61 | -$42.27 |
| Operating Income | -$8.97M | -$4.87M | -$4.87M | -$6.93M |
| Operating Income Ratio | -$17938.42 | -$92.29 | -$92.29 | -$42.27 |
| Other Income/Expenses (Net) | -$24.47M | -$598715.00 | -$598715.00 | -$1.01M |
| Income Before Tax | -$33.44M | -$5.47M | -$5.47M | -$7.94M |
| Income Before Tax Ratio | -$66877.39 | -$103.64 | -$103.64 | -$48.44 |
| Income Tax Expense | $134386.00 | $72807.00 | $72807.00 | $105214.00 |
| Net Income | -$33.57M | -$5.54M | -$5.54M | -$8.05M |
| Net Income Ratio | -$67148.16 | -$105.02 | -$105.02 | -$49.08 |
| EPS | -$0.88 | -$0.17 | -$0.17 | -$0.29 |
| Diluted EPS | -$0.88 | -$0.17 | -$0.17 | -$0.29 |
| Weighted Avg Shares Outstanding | $38.26M | $32.35M | $32.35M | $28.24M |
| Weighted Avg Shares Outstanding (Diluted) | $38.26M | $32.35M | $32.35M | $28.24M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan